The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.
about
Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating.Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People's Quality of Life Brief Questionnaire (OPQoL-Brief) Scores.Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15.Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs).Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children.Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis.Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.The Use of Mapping to Estimate Health State Utility Values.Model Registration: A Call to Action.Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement.Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement.PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT.Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP.Direct Mapping of the QLQ-C30 to EQ-5D Preferences: A Comparison of Regression Methods.Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV
P2860
Q35908125-1284ACFF-1987-4557-8891-60B3E83FBC59Q38677909-7A09D6D3-091D-45CB-8EA4-A098B0974161Q38721552-CC41CE42-1319-4FA4-8BDB-97E8282B7F21Q39121036-914E448A-23D0-4D88-851D-87AD5C1F4629Q39456662-0185A7D6-8AF5-4EF9-BED0-5719BBCA3959Q47271455-96B168BC-CFB5-48C6-87C7-F65DF52DE7EEQ47375172-5A69941A-CB6F-4F42-BB50-2A3D7A46FF54Q47673299-F8C2F687-8F7B-4C68-8D9F-A57E7786485AQ47755831-ECC7544B-BB78-4304-9B08-A079AEA0A886Q50016199-1FA19539-B0CF-40C8-8981-144EFAB3C9E3Q50057926-A6015028-0845-42A2-9025-C3442672D8E0Q51024067-ECAED7CA-D706-4545-8278-FBFA4CFFC832Q53397964-06D08A37-C799-4E78-95BE-3D0B549A74ABQ53399248-559F144C-5E20-4AD6-9A87-00C8256DB0A8Q54901654-62D4F786-0D63-4BF1-AD22-0401DC52DBA9Q55282896-93B2E499-4475-4723-AB2B-1133F85A926DQ55455489-AABA79FF-A613-4420-A503-282B8D3D8F17Q57152985-19CDEC28-ABBC-4593-BA6B-8AD1A3297540
P2860
The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The MAPS Reporting Statement f ...... : Explanation and Elaboration.
@en
type
label
The MAPS Reporting Statement f ...... : Explanation and Elaboration.
@en
prefLabel
The MAPS Reporting Statement f ...... : Explanation and Elaboration.
@en
P2860
P50
P1433
P1476
The MAPS Reporting Statement f ...... : Explanation and Elaboration.
@en
P2093
Louise Longworth
P2860
P2888
P304
P356
10.1007/S40273-015-0312-9
P577
2015-08-01T00:00:00Z